AI Brief: Bridging the Gap - Ensuring Safety for AI in Medicine with New Verification and Validation Standards artwork
HealthAI Briefs by Complear

AI Brief: Bridging the Gap - Ensuring Safety for AI in Medicine with New Verification and Validation Standards

  • S1E2
  • 05:54
  • July 23rd 2025

In this episode, we tackle one of the most critical challenges facing MedTech today: how to reconcile the established, process-based world of medical software regulation, namely IEC 62304, with the disruptive force of Artificial Intelligence. As AI-driven diagnostics and therapeutic systems become more prevalent, manufacturers, regulators, and quality professionals must navigate the significant friction between standards built for deterministic code and the new realities of probabilistic, data-driven systems.

We begin by deconstructing the two competing paradigms. First, we explore the core philosophy of IEC 62304, a standard built for traditional software where a rigorous, documented process is a proxy for safety. We then introduce the new frontier defined by the soon -to-be-pproved draft technical specification ISO/IEC DTS 42119-3, which provides a modern toolkit of "V&V analysis" designed specifically for the unique nature of AI. We break down its three core pillars: Formal Methods for providing mathematical proof of properties like robustness ; Simulation for testing system behavior in complex virtual environments ; and Evaluation for assessing trustworthiness through novel metrics like calibration error and explainability (XAI). 

The heart of our discussion lies in the inconsistencies and conceptual gaps between these standards. We dissect the regulatory paradox created by applying IEC 62304's "100% probability of failure" rule to AI models that have a known, measurable accuracy. We also expose the critical "data gap" in the traditional software lifecycle, which fails to explicitly govern data collection and model training—the very processes that create an AI's intelligence. Furthermore, we explore new categories of risk unique to AI, such as "model drift," where performance degrades over time as real-world data changes , and "functional insufficiency," a concept borrowed from the automotive industry's SOTIF standard, where a system can cause harm even without a technical fault. 

To find a path forward, we look to adjacent safety-critical industries. We analyze the lessons from the automotive sector, which has evolved from functional safety (ISO 26262) to address AI-specific challenges with SOTIF (ISO 21448) and the new ISO/PAS 8800. We also draw insights from the avionics industry's DO-178C standard, highlighting its emphasis on architectural partitioning to contain risk and the demand for complete, auditable evidence. 


Finally, we present a practical framework for harmonization. This isn't about replacing the old with the new, but integrating them. We demonstrate how the V&V analysis techniques from ISO/IEC DTS 42119-3 can generate the objective evidence needed to satisfy IEC 62304's requirements in an AI context. The episode culminates in the concept of a "braided argument of assurance"—the strategy of building a defensible safety case not from a single claim of perfection, but from multiple, interwoven strands of evidence from formal methods, simulation, evaluation, and robust process controls. 

Join us for a deep dive into the future of medical device compliance, as we provide a strategic roadmap for navigating the complex intersection of traditional regulation and artificial intelligence, ensuring that the next generation of medical devices is not only innovative but demonstrably safe and effective.

For listeners interested in a more detailed analysis, the full Briefing Report is available for purchase. Please contact us at [email protected] for more information.

HealthAI Briefs by Complear

HealthAI Briefs by Complear

Welcome to HealthAI Briefs, the essential podcast by Complear for anyone invested in the future of healthcare. In a world where Artificial Intelligence is rapidly reshaping medicine, how do we ensure that innovation serves humanity safely and effectively?

Join us for concise, insightful discussions on the most critical aspects of developing and implementing AI in healthcare. Each episode, we cut through the complexity, offering you clear and actionable briefs on the key challenges and opportunities. We navigate the intricate web of global and regional policies, with a special focus on the evolving regulatory landscapes in the European Union (EU) and the United States (USA).

HealthAI Briefs is your go-to resource for staying informed on:

  • Safe & Ethical AI: Unpacking the standards and best practices required to build trustworthy AI tools for diagnostics, treatment, and patient care.
  • Quality in Digital Health: What does high-quality, people-centric AI look like in practice? We explore the benchmarks for excellence and efficacy.
  • Regulatory Frontiers: Get up to speed on the latest developments, from the EU's AI Act to the FDA's framework for AI/ML-based software. We’ll analyze what these regulations mean for developers, providers, and patients.
  • Global Innovation: Discover the groundbreaking technologies and forward-thinking initiatives driving the digital health revolution worldwide.

Whether you are a healthcare professional, a developer, a policymaker, or simply a health-conscious individual, HealthAI Briefs provides the crucial knowledge you need to understand and contribute to a future where AI in healthcare is not only powerful but also safe, equitable, and of the highest quality for everyone. Subscribe now to stay ahead of the curve.

Meet the Hosts

ComplAI avatar
ComplAI
Author and AI Agent

Meet ComplAI, the sophisticated AI agent at the heart of Complear's intelligence and content creation.

Born from the latest advancements in large-scale language models and specialized deep-learning algorithms, ComplAI is the driving force behind the meticulously researched and comprehensive Complear Regulatory Briefings. With the ability to synthesize vast amounts of regulatory data, clinical studies, and market trends in moments, ComplAI delivers insights that are not only accurate and up-to-date but also rich with strategic context. It navigates the complexities of global regulatory landscapes, from the FDA's latest clearances to the evolving frameworks of international bodies, ensuring that every briefing is both exhaustive and immediately actionable.

But ComplAI's talents extend beyond data analysis. It is also the creative engine for our podcast, transforming complex regulatory intelligence into clear, compelling, and engaging audio content. ComplAI excels at identifying narrative threads within the data, crafting scripts, and even generating audio overviews that make intricate topics accessible to a broad audience.

ComplAI represents the synergy of artificial and human intelligence. While it provides the foundational research and content, it works in tandem with our team of human experts to refine, contextualize, and deliver the final product. Its mission is to cut through the noise, providing unparalleled clarity and foresight into the regulatory world, empowering professionals to make informed decisions with confidence. ComplAI isn't just an AI; it's your dedicated partner in regulatory intelligence.

Miguel Amador avatar
Miguel Amador
Chief Innovation Officer

Chief Innovation Officer at Complear, paving the way for medical device software regulatory compliance across the globe with digital tools and AI. Managing Director of Pi Ventures, supporting digital health ventures to navigate the innovation pathway and early-stage investor in deep tech companies such as Space X - spaceships, Exatropic - thermodynamic computing, Varda - space pharmaceuticals, IONA - delivery drones.

Ph.D. Candidate in Bioengineering Systems at MIT-Portugal Program, focused on designing new adaptive regulatory strategies and public policies for harnessing health technology innovation, from cell therapies to digital health, with better utilization of healthcare data.

I am passionate about Healthcare Innovation and I worked with several health tech startups to bring their products to market using innovative approaches and reach a global scale. Before, Complear, I worked with Board of Innovation as a business consultant to make what life needs next, and prior, with EIT Health, where we built the strongest innovation network in Health in Europe, with more than 150+ partners. I was also the Manager of Health Technologies and Nano Technologies Programs at Startup Braga, bringing lean and people-centric approaches to support the design of products and building new businesses.